Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LUMASIRAN vs LUSPATERCEPT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LUMASIRAN vs LUSPATERCEPT: Safety Overview

Metric LUMASIRAN LUSPATERCEPT
Total FAERS Reports 279 264
Deaths Reported 15 49
Death Rate 5.4% 18.6%
Hospitalizations 99 96
Average Patient Age 43.3 yrs 61.5 yrs
% Female Patients 72.7% 37.5%
FDA Approval Date Nov 23, 2020 N/A
Manufacturer Alnylam Pharmaceuticals, Inc. Celgene Corporation
Route SUBCUTANEOUS SUBCUTANEOUS
Marketing Status Prescription N/A